Treatment of adults with recurrent malignant glioma

References

• Wrensch M, Minn Y, ChewT, Bondy M, Berger MS. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro-Oncology 4, 278–299 (2002).
   PubMed Web of Science ®Google Scholar
• Lamborn K, Chang SM, Prados MD. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro-Oncol. 6, 227–235 (2004).
   PubMed Web of Science ®Google Scholar
• Aldape KD, Okcu MF, Bondy M, Wrensch M. Molecular epidemiology of glioblastoma. Cancer J. 9, 99–106 (2003).
   PubMedGoogle Scholar
• Ino Y, Betensky RA, Zlatescu MC et al. Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin. Cancer Res. 7, 839–845 (2001).
   PubMed Web of Science ®Google Scholar
• Bondy M, Wiencke J, Wrensch M, Kyritsis AP. Genetics of primary brain tumors: a review. J. Neurooncol. 18, 69–81 (1994).
   PubMed Web of Science ®Google Scholar
• Laws ER, Parney IF, Huang W et al. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J. Neurosurg. 99, 467–473 (2003).
   Google Scholar
• Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359, 1011–1018 (2002).
   PubMed Web of Science ®Google Scholar
• Stupp R, Mason WP, van den Bent MJ et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987–996 (2005).
   PubMed Web of Science ®Google Scholar
• Wong ET, Hess KR, Gleason MJ et al. Outcomes and prognostic factors in recurrent glioma patients enrolled onto Phase II clinical trials. J. Clin. Oncol. 17, 2572–2578 (1999).
   PubMed Web of Science ®Google Scholar
• Chang SM, Parney IF, McDermott M et al. Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcomes Project. J. Neurosurg. 98, 1175–1181 (2003).
   PubMed Web of Science ®Google Scholar
• Brem H, Piantadosi S, Burger PC et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Lancet 345, 1008–1012 (1995).
   PubMed Web of Science ®Google Scholar
• Li X, Jin H, Oh J, Chang SM, Nelson SJ. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas. NMR Biomed. 17, 10–20 (2004).
   PubMedGoogle Scholar
• Henson JW, Gaviani P, Gonzalez RG. MRI in treatment of adult gliomas. Lancet Oncol. 6, 167–175 (2005).
   PubMed Web of Science ®Google Scholar
• Atlas SW, Howard RS, Maldjian J et al. Functional magnetic resonance imaging of regional brain activity in patients with intracerebral gliomas: findings and implications for clinical management. Neurosurgery 38, 329–338 (1996).
   PubMed Web of Science ®Google Scholar
• Wirtz CR, Knauth M, Staubert A et al. Clinical evaluation and follow-up results for intraoperative magnetic resonance imaging in neurosurgery. Neurosurgery 46, 1112–1120 (2000).
   PubMed Web of Science ®Google Scholar
• Nimsky C, Fujita A, Ganslandt O, Von Keller B, Fahlbusch R. Volumetric assessment of glioma removal by intraoperative high-field magnetic resonance imaging. Neurosurgery 55, 358–370 (2004).
   PubMed Web of Science ®Google Scholar
• Kim HK, Thorton AF, Greenberg HS et al. Results of re-irradiation of primary intracranial neoplasms with three-dimensional conformal therapy. Am. J. Clin. Oncol. 20, 358–363 (1997).
   PubMed Web of Science ®Google Scholar
• Hudes RS, Corn BW, Werner-Wasik M et al. A Phase I dose escalation study of hypofractionated sterotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. Int. J. Radiat. Oncol. Biol. Phys. 43(2), 293–298 (1999).
   PubMed Web of Science ®Google Scholar
• Loeffler JS, Alexander E, Hochberg FH. Clinical patterns of failure following stereotactic interstitial irradiation for malignant glioma. Int. J. Radiat. Oncol. Biol. Phys. 19(6), 1455–1462 (1990).
   PubMed Web of Science ®Google Scholar
• Larson DA, Suplica JM, Chang SM et al. Permanent iodine 125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme. Neuro-Oncology 6(2), 119–126 (2004).
   Google Scholar
• Tatter SB, Shaw EG, Rosenblum ML et al. An inflatable balloon catheter and liquid 125I radiation source (Gliasite Radiation Therapy System) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial. J. Neurosurg. 99(2), 297–303 (2003).
   PubMed Web of Science ®Google Scholar
• Gabayan AJ, Sanan A, Bastin K et al. Gliasite radiotherapy system for treatment of recurrent malignant glioma: a multi-institutional analysis. Int. J. Radiat. Oncol. Biol. Phys. 60, S258 (2004).
   Google Scholar
• Shaw EG, Scott C, Souhami L et al. Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol (90–05). Int. J. Radiat. Oncol. Biol. Phys. 34(3), 647–654 (1996).
   PubMed Web of Science ®Google Scholar
• Shaw EG, Scott C, Souhami L. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and metastases: final report of RTOG protocol 90–05. Int. J. Radiat. Oncol. Biol. Phys. 47, 291–298 (2000).
   Google Scholar
• Larson DA, Gutin PH, McDermott Met al. Gamma knife for glioma: selection factors and survival. Int. J. Radiat. Oncol. Biol. Phys. 36(5), 1045–1053 (1996).
   PubMedGoogle Scholar
• Yung A, Prados M, Yaya-Tur R et al. Multicenter Phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. J. Clin. Oncol. 17, 2762–2771 (1999).
   PubMed Web of Science ®Google Scholar
• Walker MD, Aexander E, Hunt WE et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: a co-operative clinical trial. J. Neurosurg. 49, 333–343 (1978).
   PubMed Web of Science ®Google Scholar
• Walker MD, Green SB, Byar DP et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl. J. Med. 303, 1323–1329 (1980).
   Google Scholar
• Fine HA, Wen PY, Maher EA et al. Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas. J. Clin. Oncol. 21, 2299–2304 (2003).
   PubMed Web of Science ®Google Scholar
• Tanizawa A, Fujimori A, Fujimori Y et al. Comparison of topoisomerase I inhibition, DNA damage, and cytotoxicity of camptothecin derivatives presently in clinical trials. J. Natl Cancer Inst. 86, 836–842 (1994).
   PubMed Web of Science ®Google Scholar
• Friedman HS, Petros WP, Friedman A et al. Irinotecan therapy in adults with recurrent or progressive malignant glioma. J. Clin. Oncol. 17, 1516–1525 (1999).
   PubMed Web of Science ®Google Scholar
• Buckner JC, Reid JM, Wright K et al. Irinotecan in the treatment of glioma patients. Cancer 97(Suppl. 9), 2352–2358 (2003).
   PubMedGoogle Scholar
• Gilbert MR, Supko JG, Batchelor T et al. Phase I clinical and pharmacokinetic study of irinotecan in adults with recurrent malignant glioma. Clin. Cancer Res. 9, 2940–2949 (2003).
   PubMed Web of Science ®Google Scholar
• Yung WKA, Mechtler L, Gleason MJ. Intravenous carboplatin for recurrent malignant glioma: a Phase II study. J. Clin. Oncol. 9, 860–864 (1991).
   PubMed Web of Science ®Google Scholar
• Silvani A, Eoli M, Salmaggi A et al. Phase II trial of cisplatin plus temozolomide, in recurrent and progressive malignant glioma patients. J. Neurooncol. 66, 203–208 (2004).
   PubMed Web of Science ®Google Scholar
• Franceschi E, Cavallo G, Scopece L et al. Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma. Br. J. Cancer 13, 1038–1044 (2004).
   Google Scholar
• Jeremic B, Grujicic D, Jevremovic S et al. Carboplatin and etoposide chemotherapy regimen for recurrent malignant glioma: a Phase II study. J. Clin. Oncol. 10, 1074–1077 (1992).
   PubMed Web of Science ®Google Scholar